A mutational signature in gastric cancer suggests therapeutic strategies
about
Mutational signatures associated with tobacco smoking in human cancerIntegrating next-generation sequencing into clinical oncology: strategies, promises and pitfallsGastric cancer - clinical and epidemiological aspects.Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.Whole-genome analysis of papillary kidney cancer finds significant noncoding alterationsBiallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate TumorsWhen Genome Maintenance Goes Badly Awry.Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancerKIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer.A proteogenomic approach for protein-level evidence of genomic variants in cancer cells.Platelet distribution width correlates with prognosis of gastric cancer.Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas.Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.Exploring background mutational processes to decipher cancer genetic heterogeneity.Targeting deficient DNA damage repair in gastric cancer.Understanding mutagenesis through delineation of mutational signatures in human cancer.Personalised Treatment in Gastric Cancer: Myth or Reality?Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer.Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes.Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer.Actionable gene-based classification toward precision medicine in gastric cancer.The ubiquitous 'cancer mutational signature' 5 occurs specifically in cancers with deleted FHIT alleles.Computational approaches for discovery of mutational signatures in cancer.Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma.HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.Precision oncology in the age of integrative genomics.Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma.Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils.The genetic landscape of 5T models for multiple myelomaSomatic genome alterations in relation to age in lung squamous cell carcinomaWhole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer
P2860
Q28005544-5128BF72-9AEF-4F0C-B860-8C1C58DD5AFAQ28066709-11F8A267-4432-4376-A2AC-A485B9C671C1Q30248452-0DA327EB-2103-4670-8EAA-5DD70B5CFB62Q30249783-4962101C-F32C-4918-BB2F-7DA9BEB616B2Q33563168-03403F5C-7CF5-42B3-A95D-314E3B9DBC25Q36891144-146C02A2-CBA8-4217-8E96-088524E07090Q37138583-C6A5E33E-6906-4569-8942-2457E79A37AAQ37249091-44B1EFBC-DC08-40F7-A55A-68B793BC20A9Q37330144-4BEA379B-BE57-48F6-847D-C0317F8BE3CAQ37335640-96FD2701-7333-4869-B46F-C139D90E74B4Q37746289-61C64F5F-DF46-4412-A5D0-AA6C3A0F6B52Q38599134-37BBC2DD-F284-499D-90B9-A3B578911916Q38748208-F6C5F52B-1008-4E43-A036-1312A4C903F4Q38803947-19249939-A37E-4827-AFD5-EB67FC1CA40DQ38834760-47C4C838-ED73-4FD2-BFFC-7C4B213ED9BBQ38840433-C9914DE7-FD6E-4A79-8A41-9C7EC4D2EFDBQ38842137-70F7F2FE-323F-4815-A2BD-214EAACF4D64Q40407011-DB6BDB63-6470-4B92-9390-2ABA4EFC7C9FQ42261796-1655AE0F-93E5-4072-AC33-9710379D58B1Q43045850-860668D2-E41E-48F8-B435-5228AC733402Q45298756-8A1B73A8-9A77-4E2A-87B8-5C8D4D2FD192Q47113548-2C9632E9-6585-4AC3-B207-7BB7086C7BDBQ47153130-B544AF28-050B-4E5F-A50D-9AAFBB9943D2Q47664589-A4CD56F0-854B-471E-B86A-DC1342428431Q47864236-1100FF5C-0D7D-40A6-920C-639A881ABE4EQ48134701-2A74C0F7-A063-4C63-AD40-D5C752FA9674Q48305502-3F173662-EDA6-4082-9401-7063E310C6F5Q50105699-3109C43C-D6B9-4968-A857-78F360117AE9Q50578370-74E7A53F-953E-459D-BA64-F750EB3D6254Q52603962-B69D2B61-E490-42DB-AF48-C35CE2EDB8C5Q52691469-D9500249-83C1-498E-A6E9-657CB09FF225Q53074658-8B14E72E-E1F0-4BB8-B683-982874F9013BQ57292400-5C8C6115-D438-41A1-AD62-68FB4231EE7FQ58780428-6586F276-2743-4FB5-879C-23754F32719FQ59137310-DD7E6F84-5C3E-4CCB-9DDB-FD85926EEC77
P2860
A mutational signature in gastric cancer suggests therapeutic strategies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A mutational signature in gastric cancer suggests therapeutic strategies
@en
A mutational signature in gastric cancer suggests therapeutic strategies.
@nl
type
label
A mutational signature in gastric cancer suggests therapeutic strategies
@en
A mutational signature in gastric cancer suggests therapeutic strategies.
@nl
prefLabel
A mutational signature in gastric cancer suggests therapeutic strategies
@en
A mutational signature in gastric cancer suggests therapeutic strategies.
@nl
P2860
P50
P356
P1476
A mutational signature in gastric cancer suggests therapeutic strategies
@en
P2093
Hoi Cheong Siu
Suet Yi Leung
P2860
P2888
P356
10.1038/NCOMMS9683
P407
P577
2015-10-29T00:00:00Z
P5875
P6179
1049463551